DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Jones JA, Mato AR, Wierda WG. et al.
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.

Lancet Oncol 2018;
19: 65-75

Download Bibliographical Data

Search in:
Access: